High‐frequency mutation, CDKN2A, in LUSC (19.4%), was absent in SCLC (0.0%, P = 0.003, FDR = 0.032, Table S2, Supporting Information) (Figure 1C–E). This evidence concerns the gene CDKN2A and small cell lung carcinoma.